Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Evolent Health, Inc (EVH : NYSE)
 
 • Company Description   
Evolent Health, Inc. is involved in the healthcare delivery and payment markets. The company provides technology-enabled services platform for providers to transition their organization in value-based payment models. Evolent Health, Inc. is based in Arlington, Virginia.

Number of Employees: 2,900

 
 • Price / Volume Information   
Yesterday's Closing Price: $22.27 Daily Weekly Monthly
20 Day Moving Average: 601,845 shares
Shares Outstanding: 89.41 (millions)
Market Capitalization: $1,991.17 (millions)
Beta: 2.12
52 Week High: $34.60
52 Week Low: $16.81
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -19.52% -11.10%
12 Week -26.67% -20.68%
Year To Date -19.52% -11.34%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
800 NORTH GLEBE RD SUITE 500
-
ARLINGTON,VA 22203
USA
ph: 571-389-6000
fax: 571-389-6001
investorrelations@evolenthealth.com http://www.evolenthealth.com
 
 • General Corporate Information   
Officers
Seth Blackley - Chief Executive Officer and Director
John Johnson - Chief Financial Officer
Michael D'Amato - Director
Craig Barbarosh - Director
M. Bridget Duffy - Director

Peer Information
Evolent Health, Inc (CWLD)
Evolent Health, Inc (CYBA.)
Evolent Health, Inc (ZVLO)
Evolent Health, Inc (ATIS)
Evolent Health, Inc (AGIL.)
Evolent Health, Inc (EPRS.)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: INTERNET SOFTWARE
Sector: Computer and Technology
CUSIP: 30050B101
SIC: 8741
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 09/01/21
Next Expected EPS Date: 02/23/22
Share - Related Items
Shares Outstanding: 89.41
Most Recent Split Date: (:1)
Beta: 2.12
Market Capitalization: $1,991.17 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.12 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.11 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 02/23/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.15
Price/Cash Flow: 6.70
Price / Sales: 2.14
EPS Growth
vs. Year Ago Period: -14.29%
vs. Previous Quarter: -33.33%
Sales Growth
vs. Year Ago Period: -15.92%
vs. Previous Quarter: 0.19%
ROE
12/31/21 - -
09/30/21 - -3.60
06/30/21 - -3.38
ROA
12/31/21 - -
09/30/21 - -1.70
06/30/21 - -1.58
Current Ratio
12/31/21 - -
09/30/21 - 1.30
06/30/21 - 1.25
Quick Ratio
12/31/21 - -
09/30/21 - 1.30
06/30/21 - 1.25
Operating Margin
12/31/21 - -
09/30/21 - -2.38
06/30/21 - -2.17
Net Margin
12/31/21 - -
09/30/21 - -5.00
06/30/21 - -7.28
Pre-Tax Margin
12/31/21 - -
09/30/21 - -5.32
06/30/21 - -7.52
Book Value
12/31/21 - -
09/30/21 - 7.07
06/30/21 - 7.17
Inventory Turnover
12/31/21 - -
09/30/21 - -
06/30/21 - -
Debt-to-Equity
12/31/21 - -
09/30/21 - 0.35
06/30/21 - 0.34
Debt-to-Capital
12/31/21 - -
09/30/21 - 25.78
06/30/21 - 25.17
 

Powered by Zacks Investment Research ©